HealthStream, Inc. (HSTM) To Go Ex-Dividend on November 4th

HealthStream, Inc. (NASDAQ:HSTM) declared a quarterly dividend on Monday, October 21st, Zacks reports. Stockholders of record on Monday, November 4th will be given a dividend of 0.028 per share by the technology company on Friday, November 15th. This represents a $0.11 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date is Monday, November 4th.

HealthStream has a payout ratio of 17.7% indicating that its dividend is sufficiently covered by earnings. Research analysts expect HealthStream to earn $0.61 per share next year, which means the company should continue to be able to cover its $0.11 annual dividend with an expected future payout ratio of 18.0%.

HealthStream Price Performance

HSTM stock traded down $0.46 on Wednesday, reaching $29.61. 2,075 shares of the company were exchanged, compared to its average volume of 111,801. The firm has a market capitalization of $900.08 million, a PE ratio of 51.84, a PEG ratio of 4.25 and a beta of 0.36. The stock’s fifty day moving average price is $28.68 and its 200 day moving average price is $27.88. HealthStream has a 12 month low of $22.84 and a 12 month high of $31.15.

HealthStream (NASDAQ:HSTM) last issued its earnings results on Monday, October 21st. The technology company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.13 by $0.06. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The company had revenue of $73.10 million for the quarter, compared to the consensus estimate of $73.53 million. During the same quarter in the previous year, the company earned $0.13 EPS. The firm’s revenue for the quarter was up 4.0% compared to the same quarter last year. As a group, research analysts expect that HealthStream will post 0.56 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Tate Deborah Taylor sold 1,400 shares of the company’s stock in a transaction dated Thursday, August 29th. The stock was sold at an average price of $28.53, for a total value of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares of the company’s stock, valued at $636,960.78. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, Director Tate Deborah Taylor sold 1,400 shares of the stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the sale, the director now directly owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Kevin P. O’hara sold 3,000 shares of the stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the sale, the senior vice president now directly owns 9,527 shares of the company’s stock, valued at approximately $267,041.81. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 20.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on HSTM shares. Barclays upped their price target on shares of HealthStream from $32.00 to $34.00 and gave the stock an “overweight” rating in a research report on Wednesday. StockNews.com downgraded shares of HealthStream from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. Craig Hallum upgraded shares of HealthStream to a “strong-buy” rating in a research report on Thursday, October 17th. Finally, Canaccord Genuity Group boosted their price objective on HealthStream from $28.00 to $29.00 and gave the stock a “hold” rating in a report on Wednesday. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, HealthStream presently has an average rating of “Moderate Buy” and a consensus price target of $31.50.

About HealthStream

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.